Expert advisors to the US Food and Drug Administration (FDA) voted on Thursday to recommend approval of Wyeth’s bone-growth promoter InductOs for the treatment of open long-bone fractures.
InductOs is an absorbable collagen sponge soaked with the recombinant human bone morphogenetic protein 2 (rhBMP2) growth factor to provide localized therapy.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!